IPS cells to model CDKL5-related disorders

European Journal of Human Genetics

Volumn 19, Issue 12, 2011, Pages 1246-1255

  Amenduni, Mariangela ^a   De Filippis, Roberta ^a   Cheung, Aaron Y L ^b   Disciglio, Vittoria ^a   Epistolato, Maria Carmela ^a   Ariani, Francesca ^a   Mari, Francesca ^a   Mencarelli, Maria Antonietta ^a   Hayek, Youssef ^a   Renieri, Alessandra ^a   Ellis, James ^b,c   Meloni, Ilaria ^a  

^a UNIVERSITY HOSPITAL OF SIENA   (Italy)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

CDKL5; disease modelling; induced pluripotent stem cells (iPSC); Rett syndrome

Indexed keywords

ARTICLE; CDKL5 GENE; CELL DIFFERENTIATION; CONTROLLED STUDY; FEMALE; FIBROBLAST; GENE; GENE MUTATION; GENETIC DISORDER; HUMAN; HUMAN CELL; IN VITRO STUDY; KARYOTYPE; MALE; NERVE CELL; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; SEIZURE; X CHROMOSOME INACTIVATION;

CELL DIFFERENTIATION; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MALE; MUTATION; NEURONS; PROTEIN-SERINE-THREONINE KINASES; RETT SYNDROME; X CHROMOSOME INACTIVATION;

IPS;

EID: 81455141449     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/ejhg.2011.131     Document Type: Article

References (44)

1. Chahrour M, Zoghbi HY: The story of Rett syndrome: from clinic to neurobiology. Neuron 2007; 56: 422-437.
2. Hagberg BA, Skjeldal OH: Rett variants: a suggested model for inclusion criteria. Pediatr Neurol 1994; 11: 5-11.
3. Rolando S: Rett syndrome: report of eight cases. Brain Dev 1985; 7: 290-296.
4. Hanefeld F: The clinical pattern of the Rett syndrome. Brain Dev 1985; 7: 320-325.
5. Zappella M: The preserved speech variant of the Rett complex: a report of 8 cases. Eur Child Adolesc Psychiatry 1997; 6: 23-25.
6. Scala E, Ariani F, Mari F et al: CDKL5/STK9 is mutated in Rett syndrome variant with infantile spasms. J Med Genet 2005; 42: 103-107.
7. Ariani F, Hayek G, Rondinella D et al: FOXG1 is responsible for the congenital variant of Rett syndrome. Am J Hum Genet 2008; 83: 89-93.
8. Matijevic T, Knezevic J, Slavica M, Pavelic J: Rett syndrome: from the gene to the disease. Eur Neurol 2009; 61: 3-10.
9. Chahrour M, Jung SY, Shaw C et al: MeCP2, a key contributor to neurological disease, activates and represses transcription. Science 2008; 320: 1224-1229.
10. Guy J, Hendrich B, Holmes M, Martin JE, Bird A: A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome. Nat Genet 2001; 27: 322-326.
11. Chen RZ, Akbarian S, Tudor M, Jaenisch R: Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice. Nat Genet 2001; 27: 327-331.
12. Shahbazian M, Young J, Yuva-Paylor L et al: Mice with truncated MeCP2 recapitulate many Rett syndrome features and display hyperacetylation of histone H3. Neuron 2002; 35: 234-254.
13. Chao HT, Zoghbi HY, Rosenmund C: MeCP2 controls excitatory synaptic strength by regulating glutamatergic synapse number. Neuron 2007; 56: 58-65.
14. Takahashi K, Tanabe K, Ohnuki M et al: Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007; 131: 861-872.
15. Marchetto MC, Winner B, Gage FH: Pluripotent stem cells in neurodegenerative and neurodevelopmental diseases. Hum Mol Genet 2010; 19: R71-R76.
16. Chamberlain SJ, Chen PF, Ng KY et al: Induced pluripotent stem cell models of the genomic imprinting disorders Angelman and Prader-Willi syndromes. Proc Natl Acad Sci USA 2010; 107: 17668-17673.
17. Urbach A, Bar-Nur O, Daley GQ, Benvenisty N: Differential modeling of fragile X syndrome by human embryonic stem cells and induced pluripotent stem cells. Cell Stem Cell 2010; 6: 407-411.
18. Marchetto MC, Carromeu C, Acab A et al: A model for neural development and treatment of Rett syndrome using human induced pluripotent stem cells. Cell 2010; 143: 527-539.
19. Mari F, Azimonti S, Bertani I et al: CDKL5 belongs to the same molecular pathway of MeCP2 and it is responsible for the early-onset seizure variant of Rett syndrome. Hum Mol Genet 2005; 14: 1935-1946.
20. Rusconi L, Salvatoni L, Giudici L et al: CDKL5 expression is modulated during neuronal development and its subcellular distribution is tightly regulated by the C-terminal tail. J Biol Chem 2008; 283: 30101-30111.
21. Bertani I, Rusconi L, Bolognese F et al: Functional consequences of mutations in CDKL5, an X-linked gene involved in infantile spasms and mental retardation. J Biol Chem 2006; 281: 32048-32056.
22. Carouge D, Host L, Aunis D, Zwiller J, Anglard P: CDKL5 is a brain MeCP2 target gene regulated by DNA methylation. Neurobiol Dis 2010; 38: 414-424.
23. Kameshita I, Sekiguchi M, Hamasaki D et al: Cyclin-dependent kinase-like 5 binds and phosphorylates DNA methyltransferase 1. Biochem Biophys Res Commun 2008; 377: 1162-1167.
24. Chen Q, Zhu YC, Yu J et al: CDKL5, a protein associated with Rett syndrome, regulates neuronal morphogenesis via Rac1 signaling. J Neurosci 2010; 30: 12777-12786.
25. Dracopoli N, Haines J, Korf B, Morton C, Seidman C, Smith D: Current Protocols in Human Genetics. NY: John Wiley & Son, Inc., 2000.
26. Hotta A, Cheung AY, Farra N, et al: Isolation of human iPS cells using EOS lentiviral vectors to select for pluripotency. Nat Methods 2009; 6: 370-376.
27. Allen RC, Zoghbi HY, Moseley AB, Rosenblatt HM, Belmont JW: Methylation of HpaII and HhaI sites near the polymorphic CAG repeat in the human adrogen-recetor gene correlates with X chromosome inactivation. Am J Hum Genet 1992; 51: 1229-1239.
28. Pankratz MT, Li XJ, Lavaute TM, Lyons EA, Chen X, Zhang SC: Directed neural differentiation of human embryonic stem cells via an obligated primitive anterior stage. Stem Cells 2007; 25: 1511-1520.
29. Li XJ, Zhang X, Johnson MA, Wang ZB, Lavaute T, Zhang SC: Coordination of sonic hedgehog and Wnt signaling determines ventral and dorsal telencephalic neuron types from human embryonic stem cells. Development 2009; 136: 4055-4063.
30. Meloni I, Parri V, De Filippis R et al: The XLMR gene ACSL4 plays a role in dendritic spine architecture. Neuroscience 2009; 159: 657-669.
31. Artuso R: Early-onset seizure variant of Rett syndrome: definition of the clinical diagnostic criteria. Brain Dev 2010; 32: 17-24.
32. Elia M, Falco M, Ferri R et al: CDKL5 mutations in boys with severe encephalopathy and early-onset intractable epilepsy. Neurology 2008; 71: 997-999.
33. Laurent C: Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and IPSCs during reprogramming and time in culture. Cell Stem Cell 2011; 8: 106-118.
34. Hussein M: Copy number variation and selection during reprogramming to pluripotency. Nature 2011; 471: 58-62.
35. Goto T, Monk M: Regulation of X-chromosome inactivation in development in mice and humans. Microbiol Mol Biol Rev 1998; 62: 362-378.
36. Nichols J, Smith A: Naive and primed pluripotent states. Cell Stem Cell 2009; 4: 487-492.
37. Maherali N, Sridharan R, Xie W et al: Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. Cell Stem Cell 2007; 1: 55-70.
38. Hall LL, Byron M, Butler J et al: X-inactivation reveals epigenetic anomalies in most hESC but identifies sublines that initiate as expected. J Cell Physiol 2008; 216: 445-452.
39. Tchieu J, Kuoy E, Chin MH et al: Female human iPSCs retain an inactive X chromosome. Cell Stem Cell 2010; 7: 329-342.
40. Cheung AY: Isolation of MECP2-null Rett Syndrome patient hiPS cells and isogenic controls through X-chromosome inactivation. Hum Mol Genet 2011; 20: 2103-2115.
41. Zhang SC, Wernig M, Duncan ID, Brustle O, Thomson JA: In vitro differentiation of transplantable neural precursors from human embryonic stem cells. Nat Biotechnol 2001; 19: 1129-1133.
42. Hu BY, Weick JP, Yu J et al: Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency. Proc Natl Acad Sci USA 2010; 107: 4335-4340.
43. Yuan S: Cell-surface marker signatures for the isolation of neural stem cells, glia and neurons derived from human pluripotent stem cells. PLoS ONE 2011; 6: e17540.
44. Carson CT, Aigner S, Gage FH: Stem cells: The good, bad and barely in control. Nat Med 2006; 12: 1237-1238.